Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hansoh Pharmaceutical Group Company Limited (HK:3692)
HKEX:3692
Holding HK:3692?
Track your performance easily
See the Price Targets and Ratings of:
3692 Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
3692 Stock 12 Month Forecast
Average Price Target
HK$26.56
▲(48.05% Upside)
| Highest Price TargetHK$30.00 | Average Price TargetHK$26.56 | Lowest Price TargetHK$24.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
CMB International Securities
Reiterated
12/20/24
Morgan Stanley
Reiterated
12/19/24
Bernstein
Reiterated
10/29/24
Jefferies
Reiterated
10/25/24
Nomura
HK$17.23→HK$17.95
Hold
0.06%
Upside
Reiterated
08/28/24
Hansoh Pharma (3692:HK) (HNSPF) PT Raised to HK$17.95 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang raised the price target on Hansoh Pharma (3692:HK) (OTC: HNSPF) to HK$17.95 (from HK$17.23) while maintaining a Neutral rating.
Bank of America Securities
HK$16.4→HK$20.8
Buy
15.94%
Upside
Upgraded
06/07/24
BofA Securities Upgrades Hansoh Pharma (3692:HK) (HNSPF) to BuyBofA Securities analyst David Li upgraded Hansoh Pharma (3692:HK) (OTC: HNSPF) from Underperform to Buy with a price target of HK$20.80 (from HK$16.40).
HSBC
HK$18.5→HK$18.6
Buy
3.68%
Upside
Reiterated
04/02/24
Hansoh Pharma (3692:HK) (HNSPF) PT Raised to HK$18.60 at HSBCHSBC analyst Linda Shu raised the price target on Hansoh Pharma (3692:HK) (OTC: HNSPF) to HK$18.60 (from HK$18.50) while maintaining a Buy rating.
Unknown Analyst
Not Ranked
CLSA
HK$13.7→HK$19.2
Buy
7.02%
Upside
Reiterated
04/04/24
Hansoh Pharma (3692:HK) (HNSPF) PT Raised to HK$19.20 at CLSACLSA analyst John Yung raised the price target on Hansoh Pharma (3692:HK) (OTC: HNSPF) to HK$19.20 (from HK$13.70) while maintaining a Buy (1) rating.
Best Analysts Covering Hansoh Pharmaceutical Group Company Limited
Which Analyst Should I Follow If I Want to Buy HK:3692 and Sell After:
1 Month
xxx
Success Rate
3/3 ratings generated profit
Average Return
+20.87%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +20.87% per trade.
3 Months
xxx
Success Rate
2/3 ratings generated profit
Average Return
+15.53%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +15.53% per trade.
1 Year
2 Years
xxx
Success Rate
3/3 ratings generated profit
Average Return
+43.33%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +43.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
3692 Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Dec 24
Strong Buy
0
0
0
0
0
Buy
3
4
4
7
6
Hold
1
2
2
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
6
6
8
6
Each month's total comprises the sum of three months' worth of ratings.
3692 Financial Forecast
3692 Stock Forecast FAQ
What is HK:3692’s average 12-month price target, according to analysts?
Based on analyst ratings, Hansoh Pharmaceutical Group Company Limited’s 12-month average price target is HK$26.56.
What is HK:3692’s upside potential, based on the analysts’ average price target?
Hansoh Pharmaceutical Group Company Limited has 48.05% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hansoh Pharmaceutical Group Company Limited a Buy, Sell or Hold?
Hansoh Pharmaceutical Group Company Limited has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hansoh Pharmaceutical Group Company Limited’s share price target?
The average share price target for Hansoh Pharmaceutical Group Company Limited is HK$26.56. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$30.00 ,and the lowest forecast is HK$24.00. The average share price target represents 48.05% Increase from the current price of HK$17.94.
The highest analyst share price target is HK$30.00 ,and the lowest forecast is HK$24.00. The average share price target represents 48.05% Increase from the current price of HK$17.94.
What do analysts say about Hansoh Pharmaceutical Group Company Limited?
Hansoh Pharmaceutical Group Company Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Hansoh Pharmaceutical Group Company Limited?
To buy shares of HK:3692, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.